NASDAQ: MNKD - MannKind Corp
This stock is primed for a large lift following FDA's determination, currently at approximately $7.00 a share an instant lift above $11.00 can be strongly expected and a long term (12 month) share price of $20.00 can be expected.
As with all stocks it carries a risk of FDA not determining in favour, this will see a reduction in stock price. We recommend prudent investing and use of a trailing stop to protect your capital.
Follow by Email to receive our penny stock tips instantly.
This stock is primed for a large lift following FDA's determination, currently at approximately $7.00 a share an instant lift above $11.00 can be strongly expected and a long term (12 month) share price of $20.00 can be expected.
As with all stocks it carries a risk of FDA not determining in favour, this will see a reduction in stock price. We recommend prudent investing and use of a trailing stop to protect your capital.
Follow by Email to receive our penny stock tips instantly.
